These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18433957

  • 1. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
    McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G.
    Am J Kidney Dis; 2008 Sep; 52(3):454-63. PubMed ID: 18433957
    [Abstract] [Full Text] [Related]

  • 2. Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.
    Jiang X, Zhou S, Yao J, Kong X, Cui M.
    J Nephrol; 2016 Oct; 29(5):653-62. PubMed ID: 26510426
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis.
    Tian ML, Shen Y, Sun ZL, Zha Y.
    Int Urol Nephrol; 2015 May; 47(5):815-22. PubMed ID: 25862237
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D, Wang LN, Li HX, Huang P, Qu LB, Chen FY.
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [Abstract] [Full Text] [Related]

  • 5. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial.
    Ghorbani A, Omidvar B, Beladi-Mousavi SS, Lak E, Vaziri S.
    Nefrologia; 2012 Apr; 32(6):790-6. PubMed ID: 23169362
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009191. PubMed ID: 23543572
    [Abstract] [Full Text] [Related]

  • 7. Renoprotective effect of pentoxifylline in advanced chronic kidney disease.
    Kao CC, Wu MS.
    J Formos Med Assoc; 2015 Jan 28; 114(1):94. PubMed ID: 24974130
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr 28; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 9. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M, Sagheb MM.
    Ren Fail; 2010 Jan 28; 32(2):172-8. PubMed ID: 20199178
    [Abstract] [Full Text] [Related]

  • 10. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL, Chen YM, Chiang WC, Wu KD, Tsai TJ.
    Am J Kidney Dis; 2008 Sep 28; 52(3):464-74. PubMed ID: 18617301
    [Abstract] [Full Text] [Related]

  • 11. Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.
    J Nephrol; 2007 Sep 28; 20(4):410-6. PubMed ID: 17879206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
    Renke M, Tylicki L, Rutkowski P, Knap N, Zietkiewicz M, Neuwelt A, Aleksandrowicz E, Łysiak-Szydłowska W, Woźniak M, Rutkowski B.
    Acta Biochim Pol; 2010 Sep 28; 57(1):119-23. PubMed ID: 20309434
    [Abstract] [Full Text] [Related]

  • 14. Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.
    Rodríguez-Morán M, Guerrero-Romero F.
    Clin Nephrol; 2005 Aug 28; 64(2):91-7. PubMed ID: 16114784
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.
    Chen YM, Chiang WC, Lin SL, Tsai TJ.
    J Biomed Sci; 2017 Nov 13; 24(1):84. PubMed ID: 29132351
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005 Nov 13; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 18. Pentoxifylline: Evidence strong enough for renoprotection?
    Lai TS, Chiang WC, Chen YM.
    J Formos Med Assoc; 2016 Aug 13; 115(8):591-2. PubMed ID: 26817833
    [No Abstract] [Full Text] [Related]

  • 19. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep 13; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.
    MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.
    Am J Kidney Dis; 2006 Jul 13; 48(1):8-20. PubMed ID: 16797382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.